Fanconi Anemia: A Decade of Discoveries.
In 1967, Guido Fanconi, a Swiss pediatrician, described Fanconi anemia (FA) in two siblings with similar physical anom-alies and bone marrow failure.1 A few years earlier, Schroeder and colleagues had described an increase in spontaneous chromosome breaks in blood samples from patients afflicted with what was then called familial panmyelopathy,2 now known to have been FA. Since then, the field of FA research has undergone an amazing revolution, especially in the last decade. Because of its relation-ship to DNA repair and association with a susceptibility to neo-plastic transformation, FA has gained much attention, particularly following the elucidation of some of the genes that are mutated in FA patients. In 2002, the discovery of a connection between FA, breast cancer, and other well-known DNA repair diseases sparked numerous publications on the subject. In this review, we discuss the clinical and genetic aspects of FA.
Akkari
Yassmine
Y
Department of Molecular and Medical Genetics, Oregon Health ü Science University, Portland, Oregon olsonsu@ohsu.edu.
Olson
Susan
S